|From: trendtn (Rep: 161)||Date: 04/04/2018 10:08|
|Forum: Cellectis SA - Msg #115||Thread #674001209 (Rec: 0) |
Clls offering...looks to be 4-5m shares in the geeks if the Allogene Pfizer deal.
Allogene is for the most part KITE. PFE owbs 25% if the new company.
Offering is annoying but I think will be gathered up institutionally. Why..clls is cheap at 1.35b...kite sold for 10b...and clls also has crispr in addition to cart science...buy the annoying weakness.
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.